Skip to main content

Advertisement

SpringerLink
Log in

Laboratory Blood Data Have a Significant Impact on Tumor Response and Outcome in Preoperative Chemoradiotherapy for Advanced Rectal Cancer

  • Original Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Although neoadjuvant chemoradiotherapy (CRT) is the standard treatment for advanced rectal cancer (RC), markers predicting response have not been adequately defined.

Patients and Methods

In 73 cases with advanced RC, we evaluated the tumor response with the reduction rate of the longitudinal size of RC using barium enema image taken before and after CRT. Then, we retrospectively examined the association with various blood values taken before CRT. The tumor size reduction rate was significantly greater in ten CR cases than in 63 non-CR cases (p < 0.001).

Results

Interestingly, the size reduction ratio was positively associated with hemoglobin, albumin level and lymphocyte percentage in leukocytes, while being negatively associated with platelet counts, C-reactive protein and fibrinogen levels as well as neutropliles percentage. Moreover, high lymphocyte counts (>1,800/mm3) had an independent association with disease-free survival.

Conclusions

Blood data have a major impact on the tumor response to CRT. Control of host condition may improve the effectiveness of CRT in advanced RC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731–40.

    Article  PubMed  CAS  Google Scholar 

  2. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114–23.

    Article  PubMed  CAS  Google Scholar 

  3. Ortholan C, Francois E, Thomas O, Benchimol D, Baulieux J, Bosset JF, et al. Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. Dis Colon Rectum. 2006;49(3):302–10.

    Article  PubMed  Google Scholar 

  4. Hoffmann KT, Rau B, Wust P, Stroszczynski C, Hunerbein M, Schneider U, et al. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol. 2002;178(7):386–92.

    Article  PubMed  Google Scholar 

  5. Kim YH, Kim DY, Kim TH, Jung KH, Chang HJ, Jeong SY, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):761–8.

    Article  PubMed  Google Scholar 

  6. Suppiah A, Hunter IA, Cowley J, Garimella V, Cast J, Hartley JE, et al. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis. 2009;11(3):249–53.

    Article  PubMed  CAS  Google Scholar 

  7. Kristiansen C, Loft A, Berthelsen AK, Graff J, Lindebjerg J, Bisgaard C, et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum. 2008;51(1):21–5.

    Article  PubMed  Google Scholar 

  8. Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys. 2009;74(5):1461–9.

    Article  PubMed  Google Scholar 

  9. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer. 2007;109(9):1750–5.

    Article  PubMed  CAS  Google Scholar 

  10. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, et al. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009;75(3):775–81.

    Article  PubMed  Google Scholar 

  11. Konski A, Li T, Sigurdson E, Cohen SJ, Small Jr W, Spies S, et al. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009;74(1):55–9.

    Article  PubMed  CAS  Google Scholar 

  12. Kremser C, Trieb T, Rudisch A, Judmaier W, de Vries A. Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis. J Magn Reson Imaging. 2007;26(3):662–71.

    Article  PubMed  Google Scholar 

  13. Marquardt F, Rodel F, Capalbo G, Weiss C, Rodel C. Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol. 2009;185(6):371–8.

    Article  PubMed  Google Scholar 

  14. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2009;74(3):673–88.

    Article  PubMed  CAS  Google Scholar 

  15. Kikuchi M, Mikami T, Sato T, Tokuyama W, Araki K, Watanabe M, et al. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. Br J Cancer. 2009;101(1):116–23.

    Article  PubMed  CAS  Google Scholar 

  16. Jiang SM, Wang RB, Yu JM, Zhu KL, Mu DB, Xu ZF. Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma. Zhonghua Zhong Liu Za Zhi. 2008;30(8):602–5.

    PubMed  CAS  Google Scholar 

  17. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment—tumorigenesis and therapy. Nat Rev Cancer. 2005;5(11):867–75.

    Article  PubMed  CAS  Google Scholar 

  18. Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6(7):520–8.

    Article  PubMed  CAS  Google Scholar 

  19. Moulder JE, Rockwell S. Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev. 1987;5(4):313–41.

    Article  PubMed  CAS  Google Scholar 

  20. Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19–20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res. 1993;136(3):422–34.

    Article  PubMed  CAS  Google Scholar 

  21. Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 2002;7(6):492–508.

    Article  PubMed  Google Scholar 

  22. Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, et al. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. Clin Cancer Res. 2007;13(11):3395–402.

    Article  PubMed  CAS  Google Scholar 

  23. Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 2007;26(2):241–8.

    Article  PubMed  CAS  Google Scholar 

  24. De Ridder M, Van Esch G, Engels B, Verovski V, Storme G. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway. Bull Cancer. 2008;95(3):282–91.

    PubMed  Google Scholar 

  25. Schreiner P, Siracka E, Siracky J, Manka I. The effect of anemia on the radiotherapy results of the uterine cervix cancer. Neoplasma. 1975;22(6):655–60.

    PubMed  CAS  Google Scholar 

  26. Kumar P. Impact of anemia in patients with head and neck cancer. Oncologist. 2000;5 Suppl 2:13–8.

    Article  Google Scholar 

  27. Poskitt TR. Radiation therapy and the role of red blood cell transfusion. Cancer Invest. 1987;5(3):231–6.

    Article  PubMed  CAS  Google Scholar 

  28. Stone HB, Peters LJ, Milas L. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst. 1979;63(5):1229–35.

    PubMed  CAS  Google Scholar 

  29. Demaria S, Formenti SC. Sensors of ionizing radiation effects on the immunological microenvironment of cancer. Int J Radiat Biol. 2007;83(11–12):819–25.

    Article  PubMed  CAS  Google Scholar 

  30. Lorimore SA, Coates PJ, Scobie GE, Milne G, Wright EG. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? Oncogene. 2001;20(48):7085–95.

    Article  PubMed  CAS  Google Scholar 

  31. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13(9):1050–9.

    Article  PubMed  CAS  Google Scholar 

  32. Nesslinger NJ, Sahota RA, Stone B, Johnson K, Chima N, King C, et al. Standard treatments induce antigen-specific immune responses in prostate cancer. Clin Cancer Res. 2007;13(5):1493–502.

    Article  PubMed  CAS  Google Scholar 

  33. Schaue D, Comin-Anduix B, Ribas A, Zhang L, Goodglick L, Sayre JW, et al. T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res. 2008;14(15):4883–90.

    Article  PubMed  CAS  Google Scholar 

  34. Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5:47.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113–8655, Japan

    Koji Yasuda, Eiji Sunami, Kazushige Kawai, Hirokazu Nagawa & Joji Kitayama

Authors
  1. Koji Yasuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eiji Sunami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazushige Kawai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirokazu Nagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joji Kitayama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joji Kitayama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasuda, K., Sunami, E., Kawai, K. et al. Laboratory Blood Data Have a Significant Impact on Tumor Response and Outcome in Preoperative Chemoradiotherapy for Advanced Rectal Cancer. J Gastrointest Canc 43, 236–243 (2012). https://doi.org/10.1007/s12029-011-9268-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-011-9268-y

Keywords

Search

Navigation